TAH-6601

N/A

Report date: 2024/12/18 13:39:48
NME

Base Information

Drug NameTAH-6601
Drug Alias NameTAH-6601
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsLennox Gastaut Syndrome
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesTAHO Pharmaceuticals Ltd
China Registration ClassN/A

Develop Information

Active CompaniesTAHO Pharmaceuticals Ltd
Inactive CompaniesN/A
Active IndicationsLennox Gastaut Syndrome
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A